Langerhans cells favor skin flora tolerance through limited presentation of bacterial antigens and induction of regulatory T cells

Journal of Investigative Dermatology

Volumn 133, Issue 5, 2013, Pages 1240-1249

  Van Der Aar, Angelic M G ^a   Picavet, Daisy I ^a   Muller, Femke J ^a   De Boer, Leonie ^a   Van Capel, Toni M M ^a   Zaat, Sebastian A J ^a   Bos, Jan D ^a   Janssen, Hans ^b   George, Thaddeus C ^c   Kapsenberg, Martien L ^a   Van Ham, S Marieke ^a   Teunissen, Marcel B M ^a   De Jong, Esther C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c Amnis Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CYTOKINE; FC RECEPTOR IIA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN TISSUE; LANGERHANS CELL; LYMPHOCYTE PROLIFERATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SKIN FLORA; T LYMPHOCYTE;

EID: 84876692378     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.500     Document Type: Article

References (42)

1. Aliahmadi E, Gramlich R, Grützkau A et al. (2009) TLR2-activated human langerhans cells promote Th17 polarization via IL-1beta, TGF-beta and IL-23. Eur J Immunol 39:1221-30
2. Allam JP, Peng WM, Appel T et al. (2008) Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells. J Allergy Clin Immunol 121:368-74
3. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392:245-52
4. Blander JM, Medzhitov R (2006) On regulation of phagosome maturation and antigen presentation. Nat Immunol 7:1029-35
5. Borkowski TA, Letterio JJ, Farr AG et al. (1996) A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: the skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells. J Exp Med 184:2417-22
6. Burgdorf S, Kurts C (2008) Endocytosis mechanisms and the cell biology of antigen presentation. Curr Opin Immunol 20:89-95
7. Calafat J, Janssen H, Stahle-Backdahl M et al. (1997) Human monocytes and neutrophils store transforming growth factor-alpha in a subpopulation of cytoplasmic granules. Blood 90:1255-66
8. Campbell DJ, Ziegler SF (2007) FOXP3 modifies the phenotypic and functional properties of regulatory T cells. Nat Rev Immunol 7: 305-10
9. Coombes JL, Siddiqui KR, Arancibia-Carcamo CV et al. (2007) A functionally specialized population of mucosal CD103+ DCs induces Foxp3 + regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 204:1757-64
10. de Gassart A, Camosseto V, Thibodeau J et al. (2008) MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation. Proc Natl Acad Sci USA 105:3491-6
11. de Jong EC, Vieira PL, Kalinski P et al. (2002) Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse th cell-polarizing signals. J Immunol 168:1704-9
12. Duraisingham SS, Hornig J, Gotch F et al. (2009) TLR-stimulated CD34 stem cell-derived human skin-like and monocyte-derived dendritic cells fail to induce Th17 polarization of naive T cells but do stimulate Th1 and Th17 memory responses. J Immunol 183:2242-51
13. Filgueira L, Nestle FO, Rittig M et al. (1996) Human dendritic cells phagocytose and process Borrelia burgdorferi. J Immunol 157:2998-3005
14. Flacher V, Bouschbacher M, Verronese E et al. (2006) Human Langerhans cells express a specific TLR profile and differentially respond to viruses and Gram-positive bacteria. J Immunol 177:7959-67
15. Hawiger D, Inaba K, Dorsett Y et al. (2001) Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 194:769-79
16. Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5:987-95
17. Johnson JP, Meo T, Riethmuller G et al. (1982) Direct demonstration of an HLA-DR allotypic determinant on the low molecular weight (beta) subunit using a mouse monoclonal antibody specific for DR3. J Exp Med 156:104-11
18. Jurkin J, Schichl YM, Koeffel R et al. (2010) miR-146a is differentially expressed by myeloid dendritic cell subsets and desensitizes cells to TLR2-depen-dent activation. J Immunol 184:4955-65
19. Kalinski P, Lebre MC, Kramer D et al. (2003) Analysis of the CD4+ T cell responses to house dust mite allergoid. Allergy 58:648-56
20. Kapsenberg ML (2003) Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 3:984-93
21. Klechevsky E, Liu M, Morita R et al. (2009) Understanding human myeloid dendritic cell subsets for the rational design of novel vaccines. Hum Immunol 70:281-8
22. Kretschmer K, Apostolou I, Hawiger D et al. (2005) Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6:1219-27
23. Kyei GB, Vergne I, Chua J et al. (2006) Rab14 is critical for maintenance of Mycobacterium tuberculosis phagosome maturation arrest. EMBO J 25:5250-9
24. Lebre MC, van der Aar AM, van Baarsen L et al. (2007) Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. J Invest Dermatol 127:331-41
25. Menges M, Rossner S, Voigtlander C et al. (2002) Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med 195:15-21
26. Michiels A, Tuyaerts S, Bonehill A et al. (2005) Electroporation of immature and mature dendritic cells: implications for dendritic cell-based vaccines. Gene Ther 12:772-82
27. Nestle FO, Filgueira L, Nickoloff BJ et al. (1998) Human dermal dendritic cells process and present soluble protein antigens. J Invest Dermatol 110:762-6
28. Peiser M, Koeck J, Kirschning CJ et al. (2008) Human Langerhans cells selectively activated via Toll-like receptor 2 agonists acquire migratory and CD4+T cell stimulatory capacity. J Leukoc Biol 83:1118-27
29. Peña-Cruz V, McDonough SM, Diaz-Griffero F et al. (2010) PD-1 on immature and PD-1 ligands on migratory human Langerhans cells regulate antigen-presenting cell activity. J Invest Dermatol 130:2222-30
30. Rooijakkers SH, Van Wamel WJ, Ruyken M et al. (2005) Anti-opsonic properties of staphylokinase. Microbes Infect 7:476-84
31. Rowden G, Lewis MG, Sullivan AK (1977) Ia antigen expression on human epidermal Langerhans cells. Nature 268:247-8
32. Souwer Y, Chamuleau ME, van de Loosdrecht AA et al. (2009) Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival. Br J Haematol 145:334-43
33. Steinman RM, Hawiger D, Nussenzweig MC (2003) Tolerogenic dendritic cells. Annu Rev Immunol 21:685-711
34. Takeuchi J, Watari E, Shinya EN et al. (2003) Down-regulation of Toll-like receptor expression in monocyte-derived Langerhans cell-like cells: implications of low-responsiveness to bacterial components in the epidermal Langerhans cells. Biochem Biophys Res Commun 306:674-9
35. Teunissen MBM, Haniffa M, Collin MP (2012) Insight into the immunobiology of human skin and functional specialization of skin dendritic cell subsets to innovate intradermal vaccination design. Curr Top Microbiol Immunol 351:25-76
36. Thomas RM, Belsito DV, Huang C et al. (2001) Appearance of Langerhans cells in the epidermis of Tgfb1(-/-) SCID mice: paracrine and autocrine effects of transforming growth factor-beta 1 and-beta 2(1). J Invest Dermatol 117:1574-80
37. Trombetta ES, Mellman I (2005) Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 23:975-1028
38. Turner MS, Kane LP, Morel PA (2009) Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion. J Immunol 183:4895-903
39. van der Aar AM, Sylva-Steenland RM, Bos JD et al. (2007) Loss of TLR2, TLR4, and TLR5 on Langerhans cells abolishes bacterial recognition. J Immunol 178:1986-90
40. van der Aar AMG, Sibiryak DS, Bakdash G et al. (2011) Vitamin D3 targets epidermal and dermal dendritic cells for induction of distinct regulatory T cells. J Allergy Clin Immunol 127:1532-40
41. Vignali DA, Collison LW, Workman CJ (2008) How regulatory T cells work. Nat Rev Immunol 8:523-32
42. Vroling AB, Jonker MJ, Luiten S et al. (2008) Primary nasal epithelium exposed to house dust mite extract shows activated expression in allergic individuals. Am J Respir Cell Mol Biol 38:293-9